Suzanne R. Hayman, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Suzanne R. Hayman, MD

Suzanne R. Hayman, MD

Healthcare Professional
Consultant
Division of Hematology
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States

Suzanne R. Hayman is a Consultant in the Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota. She did her MD from Mount Sinai School of Medicine in 1991 followed by residency in internal medicine from Barnes Hospital, Washington University, St. Louis, Missouri. In 2002, she obtained fellowship in Hematology/Oncology from Mayo Clinic College of Medicine. She also completed Postdoctoral Research Fellowship from the Department of Medical Genetics and Genomic Biology, Hospital for Sick Children Research Institute.

Dr. Hayman’s primary interests are into multiple myeloma, amyloidosis and lymphoproliferative disorders. Dr. Hayman has a research focus on treatment of patients with dysproteinemia. She performs clinical trials in NCCTG, ECOG, Myeloma SPORE and Mayo in the area of multiple myeloma and amyloidosis. She has a special research focus in Waldenstrom macroglobulinemia. She is a member of the Mayo Clinic Stem Cell Transplant Group.

 

Representative Publications:

Natural history of multiple myeloma with de novo del (17p)

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma 

Substratification of patients with newly diagnosed standard-risk multiple myeloma

view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close